Minerva Neurosciences, Inc. (Minerva Neurosciences, Inc) aktie
NERV
After-hours$4.8400-0.0700 (-1.43%)
Post-Market:$4.8200-0.02 (-0.41%)
Laddar diagram...
Minerva Neurosciences, Inc
Market Cap
$225,489,360
Öppning4.9100
Högsta5.2600
Lägsta4.8250
Volym92.88k
P/EN/A
Börsvärde225.49M
52 veckors högsta12.4600
52 veckors lägsta1.5500
Genomsnittlig volym258.87k
UtdelningN/A
Beta-0.10
EPS-37.0300
Om Minerva Neurosciences, Inc. (Minerva Neurosciences, Inc) aktie
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Företagsinformation
Börs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Bioteknologi
Adress:
1500 District Avenue
01803 Burlington, United States
01803 Burlington, United States
Telefon: + 617 600 7373
Hemsida: https://www.minervaneurosciences.com
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.
Anbefaling:2.67 - hold
Lägsta kursmål
7.00
↑ 44.6%
Genomsnittligt kursmål
9.50
↑ 96.3%
Median kursmål
7.50
↑ 55.0%
Högsta kursmål
14.00
↑ 189.3%